These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18600086)

  • 21. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genotyping of hemophilia A in Saudi Arabia: report of 2 novel mutations.
    Owaidah TM; Alkhail HA; Zahrani HA; Musa AA; Saleh MA; Riash MA; Alodaib A; Abu Amero K
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):415-8. PubMed ID: 19448530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype.
    Margaglione M; Castaman G; Morfini M; Rocino A; Santagostino E; Tagariello G; Tagliaferri AR; Zanon E; Bicocchi MP; Castaldo G; Peyvandi F; Santacroce R; Torricelli F; Grandone E; Mannucci PM;
    Haematologica; 2008 May; 93(5):722-8. PubMed ID: 18387975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy.
    Santacroce R; Santoro R; Sessa F; Iannaccaro P; Sarno M; Longo V; Gallone A; Vecchione G; Muleo G; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):197-202. PubMed ID: 18388498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII gene inversions in severe hemophilia A patients.
    Van de Water NS; Williams R; Nelson J; Browett PJ
    Pathology; 1995 Jan; 27(1):83-5. PubMed ID: 7603762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A.
    Bogdanova N; Markoff A; Eisert R; Wermes C; Pollmann H; Todorova A; Chlystun M; Nowak-Göttl U; Horst J
    Hum Mutat; 2007 Jan; 28(1):54-60. PubMed ID: 16972227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients.
    Abou-Elew H; Ahmed H; Raslan H; Abdelwahab M; Hammoud R; Mokhtar D; Arnaout H
    Ann Hematol; 2011 May; 90(5):579-84. PubMed ID: 21072517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A.
    Andrikovics H; Klein I; Bors A; Nemes L; Marosi A; Váradi A; Tordai A
    Haematologica; 2003 Jul; 88(7):778-84. PubMed ID: 12857556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A.
    Bagnall RD; Waseem N; Green PM; Giannelli F
    Blood; 2002 Jan; 99(1):168-74. PubMed ID: 11756167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIII mutations in 42 Moldovan haemophilia A families, including 12 that are novel.
    Sirocova N; Tsourea V; Vicol M; Barbacar N; Nakaya SM; Thompson AR; Pratt KP
    Haemophilia; 2009 Jul; 15(4):942-51. PubMed ID: 19473408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.
    Pandey GS; Yanover C; Miller-Jenkins LM; Garfield S; Cole SA; Curran JE; Moses EK; Rydz N; Simhadri V; Kimchi-Sarfaty C; Lillicrap D; Viel KR; Przytycka TM; Pierce GF; Howard TE; Sauna ZE;
    Nat Med; 2013 Oct; 19(10):1318-24. PubMed ID: 24037092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. F8 gene mutation profile in Indian hemophilia A patients: Identification of 23 novel mutations and factor VIII inhibitor risk association.
    Pinto P; Ghosh K; Shetty S
    Mutat Res; 2016 Apr; 786():27-33. PubMed ID: 26897466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A.
    Abdulqader AMR; Mohammed AI; Rachid S; Ghoraishizadeh P; Mahmood SN
    Clin Appl Thromb Hemost; 2020; 26():1076029619888293. PubMed ID: 31994403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII.
    Cai XH; Wang XF; Dai J; Fang Y; Ding QL; Xie F; Wang HL
    J Thromb Haemost; 2006 Sep; 4(9):1969-74. PubMed ID: 16805874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic alterations in the F8 gene correlating with severe hemophilia A in Egyptian patients.
    Mosaad RM; Amr KS; Rabie EA; Mostafa NO; Habib SA; El-Kamah GY
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1575. PubMed ID: 33342086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks.
    Rossetti LC; Szurkalo I; Radic CP; Abelleyro MM; Primiani L; Neme D; Candela M; Bianco RP; de Tezanos Pinto M; Larripa IB; De Brasi CD
    Haemophilia; 2013 Jul; 19(4):511-8. PubMed ID: 23534532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs.
    Wu Y; Hu Z; Li Z; Pang J; Feng M; Hu X; Wang X; Lin-Peng S; Liu B; Chen F; Wu L; Liang D
    Sci Rep; 2016 Jan; 6():18865. PubMed ID: 26743572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.